![](/img/cover-not-exists.png)
14027 Long-term efficacy and safety of continuous q12w risankizumab: Results from the open-label extension LIMMitless trial
Papp, Kim, Lebwohl, Mark, Zeng, Jiewei, Rubant, Simone, Valdes, Joaquin, Leonardi, CraigVolume:
83
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2020.06.154
Date:
December, 2020
File:
PDF, 332 KB
2020